Clinical pharmacokinetics of the phosphate binder lanthanum carbonate.
about
Lanthanum carbonate for the control of hyperphosphatemia in chronic renal failure patients: a new oral powder formulation - safety, efficacy, and patient adherenceLanthanum carbonate: safety data after 10 yearsIn situ imaging of metals in cells and tissuesPharmacology, efficacy and safety of oral phosphate binders.Lanthanum carbonate for the treatment of hyperphosphatemia in CKD 5D: multicenter, double blind, randomized, controlled trial in mainland China.Management of hyperphosphatemia in patients with end-stage renal disease: focus on lanthanum carbonate.Randomized clinical trial of the iron-based phosphate binder PA21 in hemodialysis patients.Phosphate binders for the treatment of hyperphosphatemia in chronic kidney disease patients on dialysis: a comparison of safety profiles.Efficacy of colestilan in the treatment of hyperphosphataemia in renal disease patients.Efficacy and safety of lanthanum carbonate versus calcium-based phosphate binders in patients with chronic kidney disease: a systematic review and meta-analysis.Possibility of lanthanum absorption in the stomach.Regulatory framework on bioequivalence criteria for locally acting gastrointestinal drugs: the case for oral modified release mesalamine formulations.Lanthanum carbonate delays progression of coronary artery calcification compared with calcium-based phosphate binders in patients on hemodialysis: a pilot study.Lanthanum-Induced Gastrointestinal Histiocytosis.Effect of lanthanum carbonate treatment on bone in Japanese dialysis patients with hyperphosphatemia.Acute functional neurotoxicity of lanthanum(III) in primary cortical networks.Lanthanum deposition in a dialysis patient.Extensive lanthanum deposition in the gastric mucosa: the first histopathological report.Lanthanum salts improve bone formation in a small animal model of post-menopausal osteoporosis.High Sensitive Sensor Based on Carbon Nanotube Electrode for Determination of Lanthanum in the Presence of Calcon Carboxylic Acid
P2860
Q27013882-7B989DAB-20CC-4728-94B9-B561F581C126Q28079982-0A0A69A6-4654-4D5A-8A17-DE6504CC0F10Q28662002-F304B8DC-649B-4DCD-B0ED-7DFDC61CF05CQ34213752-9D97E425-1C31-4098-BB00-7F618D5210F9Q34573734-A1FE7E57-8B55-4000-9F38-9491BF30B280Q35026657-9A21DB06-B2B2-4C94-94FD-050742937E82Q36583383-999E7050-F372-433B-9B2F-2BB987CC249BQ38202179-6D248B72-C9D4-46FA-9A8C-8A95EF6C027DQ38219038-395DB6A2-D8DF-44AA-8B20-C320C5460239Q38268395-BAE39123-4944-4AB8-8ADA-8A17B7110FEBQ38959324-63071E7A-A6A0-42A2-B3A5-B5E018058E1BQ39401950-2442FD5B-C09B-490E-B966-3F43CBD23438Q39430387-6B30B429-CB9D-45DF-81ED-F42B96497699Q40148090-BEF6945E-3A2F-4FA2-8D93-00AB79ACA112Q42594742-9D95C27E-FE40-4DE1-BDC1-E3812FB26B51Q42773959-4CE36C81-D73C-4043-AEE5-C605438C6FF8Q45922756-55A1BFF0-C385-4763-8E5F-70CB5092A04CQ51075765-A645FF18-4878-4472-8E8D-03E28EC40B0AQ51321748-60922624-B2CC-4AC8-ACA5-00B69164E511Q58253151-426DA03B-7163-4755-9437-263B9BE272B5
P2860
Clinical pharmacokinetics of the phosphate binder lanthanum carbonate.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Clinical pharmacokinetics of the phosphate binder lanthanum carbonate.
@en
Clinical pharmacokinetics of the phosphate binder lanthanum carbonate.
@nl
type
label
Clinical pharmacokinetics of the phosphate binder lanthanum carbonate.
@en
Clinical pharmacokinetics of the phosphate binder lanthanum carbonate.
@nl
prefLabel
Clinical pharmacokinetics of the phosphate binder lanthanum carbonate.
@en
Clinical pharmacokinetics of the phosphate binder lanthanum carbonate.
@nl
P2860
P1476
Clinical pharmacokinetics of the phosphate binder lanthanum carbonate.
@en
P2093
Michael Pennick
Stephen J P Damment
P2860
P304
P356
10.2165/00003088-200847090-00001
P577
2008-01-01T00:00:00Z
P6179
1001426321